References
- Korman N. J. Pemphigus. Dermatol Clin 1990; 8: 689–700
- Tallab T., Joharji H., Bahamdan K., Karkashan E., Morad M., Ibrahim K. The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol 2001; 40: 570–2
- Tsankov N., Vassileva S., Kamarashev J., Kazandjieva J., Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria. A 16‐year retrospective study (1980–1995). Int J Dermatol 2000; 39: 104–8
- Chams S., Valikhani M., Daneshpazhooh M., Esmaili N., Balighi K., Hallaji Z., et al. Pemphigus: Analysis of 1209 cases. Int J Dermatol 2005; 44: 470–6
- Lever W. F., Schaumburg‐Lever G. Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol 1984; 120: 44–7
- Ahmed A. R., Graham J., Jordon R., Provost T. Pemphigus: Current concepts. Ann Int Med 1980; 92: 396–405
- Carson P. J., Hameed A., Ahmed A. R. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645–52
- Lever W. F., Schaumburg‐lever G. Immunosuppressants and prednisone in pemphigus vulgaris: Therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol 1977; 113: 1236–41
- Bystryn J. C., Steinman N. M. The adjuvant therapy of pemphigus, an update. Arch Dermatol 1996; 132: 203–12
- Werth V. P. Treatment of pemphigus vulgaris with brief, high dose intravenous glucocorticoids. Arch Dermatol 1996; 132: 1435–9
- Nousari H. C., Anhalt G. J. Pemphigus and bullous pemphigoid. Lancet 1999; 354: 667–72
- Roujeau J. Pulse glucocorticoid therapy, the big shot revisited. Arch Dermatol 1996; 132: 1499–502
- Pasrischa J. S., Khaitan B. K., Raman S., Chadra M. Dexamethasone‐cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995; 34: 875–82
- Kanwar A. J., Dhar S. Factors responsible for death in patients with pemphigus. J Dermatol 1994; 21: 655–9
- Ahmed A. R., Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 221–8
- Gallant C., Kenny P. Oral glucocorticoids and their complications; a review. J Am Acad Dermatol 1986; 14: 161–77
- Toth G. G., Kloosterman C., Uges D. R., Jonkman M. F. Pharmacokinetics of high‐dose oral and intravenous dexamethasone. Ther Drug Monit 1999; 21: 532–5
- Hayag M. V., Cohen J. A., Kerdel F. A. Immunoablative high dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1065–9
- Euler H. H., Loffler H., Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol 1987; 123: 1205–10
- Ahmed A. R., Hombal S. Use of cyclophosphamide in azathioprine failures in pemphigus. J Am Acad Dermatol 1987; 17: 437–42
- Cummins D. L., Mimouni D., Anhalt G. J., Nousari C. H. Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus. J Am Acad Dermatol 2003; 49: 267–80
- Fleischli M. E., Valek R. H., Pandya A. G. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999; 135: 57–61
- Kaur S., Kanwar A. J. Dexamethasone‐cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990; 29: 371–4
- Fellner M. J., Katz J. M., McCabe J. B. Successful treatment of cyclophosphamide and prednisolone for initial treatment of pemphigus vulgaris. Arch Dermatol 1978; 114: 889–94
- Kumrah L., Ramam M., Shah P., Pandey R. M., Pasrichia J. S. Pituitary‐adrenal function – following dexamethasone‐cyclophosphamide pulse therapy for pemphigus. Br J Dermatol 2001; 145: 944–8